TRANSCONTINENTAL REALTY INVESTORS INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that TRANSCONTINENTAL REALTY INVESTORS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.06M | Mar 12, 2026 |
| FY2025 | Sep 30, 2025 | $12.84M | Mar 12, 2026 |
| FY2025 | Jun 30, 2025 | $12.16M | Mar 12, 2026 |
| FY2025 | Mar 31, 2025 | $12.01M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $11.79M | Mar 12, 2026 |
| FY2025 | Sep 30, 2024 | $11.61M | Mar 12, 2026 |
| FY2025 | Jun 30, 2024 | $11.77M | Mar 12, 2026 |
| FY2025 | Mar 31, 2024 | $11.90M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $13.45M | Mar 20, 2025 |
| FY2024 | Sep 30, 2023 | $12.53M | Mar 20, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.29M | Mar 12, 2026 |
| FY2025 | Sep 30, 2025 | $724.0K | Mar 12, 2026 |
| FY2025 | Jun 30, 2025 | $169.0K | Mar 12, 2026 |
| FY2025 | Mar 31, 2025 | $4.62M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $108.0K | Mar 12, 2026 |
| FY2025 | Sep 30, 2024 | $1.71M | Mar 12, 2026 |
| FY2025 | Jun 30, 2024 | $1.50M | Mar 12, 2026 |
| FY2025 | Mar 31, 2024 | $2.55M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | ($2.56M) | Mar 20, 2025 |
| FY2024 | Sep 30, 2023 | $4.45M | Mar 20, 2025 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($3.49M) | Mar 12, 2026 |
| FY2025 | Sep 30, 2025 | ($1.40M) | Mar 12, 2026 |
| FY2025 | Jun 30, 2025 | ($825.0K) | Mar 12, 2026 |
| FY2025 | Mar 31, 2025 | ($635.0K) | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | ($1.69M) | Mar 12, 2026 |
| FY2025 | Sep 30, 2024 | ($1.67M) | Mar 12, 2026 |
| FY2025 | Jun 30, 2024 | ($1.08M) | Mar 12, 2026 |
| FY2025 | Mar 31, 2024 | ($1.33M) | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | ($2.13M) | Mar 20, 2025 |
| FY2024 | Sep 30, 2023 | ($1.78M) | Mar 20, 2025 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.89M) | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.31M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | ($31.07M) | Mar 12, 2026 |
| FY2024 | Dec 31, 2022 | ($45.39M) | Mar 20, 2025 |
| FY2023 | Dec 31, 2021 | ($10.99M) | Mar 21, 2024 |
| FY2022 | Dec 31, 2020 | $5.63M | Mar 23, 2023 |
| FY2021 | Dec 31, 2019 | ($35.75M) | Mar 29, 2022 |
| FY2020 | Dec 31, 2018 | ($181.19M) | Mar 26, 2021 |
| FY2019 | Dec 31, 2017 | ($25.07M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2016 | $2.21M | Apr 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.13B | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.07B | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $1.04B | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | $1.22B | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | $788.41M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $879.08M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $865.92M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $862.38M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $1.31B | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $1.19B | Apr 2, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $266.36M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $217.73M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $196.09M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | $377.55M | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | $416.80M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $517.55M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $511.85M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $481.98M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $1.11B | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $961.44M | Apr 2, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $846.73M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $832.28M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $826.01M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | $819.47M | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | $351.21M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $341.81M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $332.60M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $359.72M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $189.17M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $205.89M | Apr 2, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $584.60M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $570.79M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $564.93M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | $558.99M | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | $90.73M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $81.33M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $74.67M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $101.59M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($79.87M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($64.05M) | Apr 2, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.07M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $19.92M | Mar 12, 2026 |
| FY2025 | Dec 31, 2023 | $36.70M | Mar 12, 2026 |
| FY2025 | Dec 31, 2022 | $113.42M | Mar 12, 2026 |
| FY2024 | Dec 31, 2021 | $50.74M | Mar 20, 2025 |
| FY2023 | Dec 31, 2020 | $36.76M | Mar 21, 2024 |
| FY2022 | Dec 31, 2019 | $51.18M | Mar 23, 2023 |
| FY2021 | Dec 31, 2018 | $36.36M | Mar 29, 2022 |
| FY2020 | Dec 31, 2017 | $42.71M | Mar 26, 2021 |
| FY2017 | Dec 31, 2016 | $17.51M | Apr 2, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $210.83M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | $181.86M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | $179.14M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | $184.46M | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | $176.75M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | $236.07M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $241.53M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | $277.24M | Mar 30, 2020 |
| FY2017 | Dec 31, 2017 | $894.48M | Apr 2, 2018 |
| FY2016 | Dec 31, 2016 | $841.52M | Mar 31, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Sep 30, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Jun 30, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Mar 31, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Sep 30, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Jun 30, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Mar 31, 2024 | 0 | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 20, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Mar 20, 2025 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Sep 30, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Jun 30, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Mar 31, 2025 | 0 | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Sep 30, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Jun 30, 2024 | 0 | Mar 12, 2026 |
| FY2025 | Mar 31, 2024 | 0 | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 20, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Mar 20, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8.64M | Mar 12, 2026 |
| FY2025 | Dec 31, 2024 | 8.64M | Mar 12, 2026 |
| FY2024 | Dec 31, 2023 | 8.64M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | 8.64M | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | 8.64M | Mar 23, 2023 |
| FY2021 | Dec 31, 2020 | 8.64M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | 8.64M | Mar 26, 2021 |
| FY2019 | Dec 31, 2018 | 8.72M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | 8.72M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | 8.72M | Apr 2, 2018 |